Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PARAINFLUENZA 1

K-Number: K843665 · 1985-09-26

ApplicantInstitute Virion , Ltd.
Decision Date1985-09-26
Product CodeGQS
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

PARAINFLUENZA 1 is the device name listed in this FDA 510(k) record. The listed applicant is Institute Virion , Ltd.. It received FDA 510(k) clearance on 1985-09-26 under 510(k) number K843665. The device is classified under product code GQS. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PARAINFLUENZA 1?

PARAINFLUENZA 1 is a medical device that received FDA 510(k) clearance on 1985-09-26. The listed applicant is Institute Virion , Ltd.. The 510(k) number is K843665.

When did PARAINFLUENZA 1 receive FDA 510(k) clearance?

PARAINFLUENZA 1 received FDA 510(k) clearance on 1985-09-26, under 510(k) number K843665.

Who is the listed applicant for PARAINFLUENZA 1?

The FDA 510(k) record lists Institute Virion , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PARAINFLUENZA 1?

The FDA product code for PARAINFLUENZA 1 is GQS.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Institute Virion , Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K862814COMPLEMENT-FIXATION TEST FOR CAMPYLOBACTER JEJUNIK843662MEASLES VIRUS RUBEOLAK843660IN FLUENZA B VIRUSK843657CYTOMEGALOVIRUSK843658H. SIMPLEX VIRUSK843673RESPIRATORY SYNCYTIAL VIRUS

View all 16 devices →

Related Devices (Code: GQS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K093415D3 FASTPOINT L-DFA PARAINFLUENZA VIRUS/ADENOVIRUS IDENTIFICATION KITDiagnostic Hybrids, Inc.K943557IMAGENDako Diagnostics , Ltd.K905385P.I.V. COMPLEMENT-FIXATION (C.F.) ANTIGENVirion (U.S.), Inc.K884194PARAINFLUENZA TYPE 1 IFA TEST KIT FOR ANTI. DETECTBaxter Diagnostics, Inc.K884193PARAINFLUENZA TYPE 3 IFA TEST KIT FOR ANTI. DETECTBaxter Diagnostics, Inc.K871228ANTIBODY ASSAY FOR DETECT. OF PARAINFLUENZA TYPE 2Microscan Div. Baxter Healthcare Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑